H3-K9me3(Histone 3 lysine 9 trimethylation) is a critical epigenetic mark associated with transcriptional repression and heterochromatin formation. In pharmaceutical R&D, targeting H3K9me3 and its regulatory enzymes offers therapeutic potential for diseases involving aberrant gene expression, such as cancer and neurological disorders. Modulating H3K9me3 levels through small molecules or peptides could provide innovative strategies for precision medicine, enabling selective control of gene expression and disease-specific treatments.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.